METSERA INC (MTSR) Stock Price, Quote, News and Overview
NASDAQ:MTSR - Nasdaq - US59267L1070 - Common Stock - Currency: USD
MTSR Quote, Performance and Key Statistics
25.65
+2.29 (+9.8%)
The current stock price of MTSR is 25.65 USD. In the past month the price increased by 21.28%.
MTSR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.33 | 351.09B | ||
| AMGN | AMGEN INC | 13.55 | 151.20B | ||
| GILD | GILEAD SCIENCES INC | 13.4 | 129.08B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1728.1 | 128.84B | ||
| REGN | REGENERON PHARMACEUTICALS | 13.67 | 65.39B | ||
| ARGX | ARGENX SE - ADR | 341.93 | 39.67B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 33.74B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.57B | ||
| BNTX | BIONTECH SE-ADR | N/A | 25.23B | ||
| NTRA | NATERA INC | N/A | 21.18B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 20.72B | ||
| BIIB | BIOGEN INC | 7.81 | 18.10B |
Related stock screener links
About MTSR
Company Profile
Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. The company is headquartered in New York City, New York and currently employs 74 full-time employees. The company went IPO on 2025-01-31. The firm uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization, or HALO, half-life extending platform and its MOMENTUM oral NuSH analog peptide delivery platform to deliver highly differentiated product candidates. Its product pipeline includes MET-097i, MET-233i / MET-233i + MET-097i and MET-224o. MET-097i, its advanced product candidate, is a fully biased, monthly, subcutaneously injectable ultra-long acting GLP-1 RA. MET-233i is a subcutaneously injectable ultra-long-acting amylin analog, with enhanced solubility and miscibility with its other NuSH analog peptides. MET-224o is an oral, fully biased ultra-long acting GLP-1 RA. The firm's pipeline also includes MET-002o, MET-AMYo, MET-034i, MET-067i and MET-PYYi.
Company Info
METSERA INC
3 World Trade Center, 175 Greenwich Street
New York City NEW YORK US
Employees: 74
Phone: 12127846595
METSERA INC / MTSR FAQ
What is the stock price of METSERA INC today?
The current stock price of MTSR is 25.65 USD. The price increased by 9.8% in the last trading session.
What is the ticker symbol for METSERA INC stock?
The exchange symbol of METSERA INC is MTSR and it is listed on the Nasdaq exchange.
On which exchange is MTSR stock listed?
MTSR stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for METSERA INC stock?
8 analysts have analysed MTSR and the average price target is 47.94 USD. This implies a price increase of 86.9% is expected in the next year compared to the current price of 25.65. Check the METSERA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is METSERA INC worth?
METSERA INC (MTSR) has a market capitalization of 2.69B USD. This makes MTSR a Mid Cap stock.
How many employees does METSERA INC have?
METSERA INC (MTSR) currently has 74 employees.
What are the support and resistance levels for METSERA INC (MTSR) stock?
METSERA INC (MTSR) has a support level at 21.25 and a resistance level at 27.53. Check the full technical report for a detailed analysis of MTSR support and resistance levels.
Should I buy METSERA INC (MTSR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MTSR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MTSR, evaluating the profitability, health, valuation and growth aspects
- METSERA INC (MTSR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- METSERA INC (MTSR) Sales and EPS estimates to see what analysts future expectations are.
- METSERA INC (MTSR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- METSERA INC (MTSR) Insider and Institutional Ownership to learn about the owners and their transactions.
- METSERA INC (MTSR) Stock Chart to make your own analysis
- METSERA INC (MTSR) Latest news and press-releases to stay up to date.
Does METSERA INC (MTSR) stock pay dividends?
MTSR does not pay a dividend.
What is the Price/Earnings (PE) ratio of METSERA INC (MTSR)?
METSERA INC (MTSR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.03).
What is the Short Interest ratio of METSERA INC (MTSR) stock?
The outstanding short interest for METSERA INC (MTSR) is 8.22% of its float. Check the ownership tab for more information on the MTSR short interest.
MTSR Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to MTSR.
MTSR Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to MTSR. MTSR has a great financial health rating, but its profitability evaluates not so good.
MTSR Financial Highlights
Over the last trailing twelve months MTSR reported a non-GAAP Earnings per Share(EPS) of -2.03. The EPS decreased by -342.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -46.37% | ||
| ROE | -72.78% | ||
| Debt/Equity | 0 |
MTSR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 85% to MTSR. The Buy consensus is the average rating of analysts ratings from 8 analysts.